Ovagen 20 mg

Ovagen is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified among the tissue-targeted oligopeptides, Ovagen was designed to investigate how minimal peptide sequences interact with ovarian tissue and female reproductive cell models. Its compact tripeptide structure positions Ovagen as a useful research compound for studying tissue-specific peptide signaling in laboratory settings.

At the cellular and molecular level, Ovagen is studied for its proposed ability to engage with chromatin and modulate transcriptional activity within ovarian cell models. Research observations suggest that short bioregulator peptides may interact with specific DNA regions to influence the expression of genes associated with follicular development, steroidogenic signaling, and reproductive-tissue homeostasis. These observations are consistent with the broader Khavinson framework, which proposes that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Ovagen centers on folliculogenesis research models, ovarian-tissue gene expression studies, and investigations of age-related decline in reproductive cell signaling. Comparative work on tissue-specific bioregulators positions Ovagen alongside other ovarian-targeted oligopeptides used to explore peptidergic regulation of female reproductive biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how short peptides modulate proliferation, differentiation, and apoptosis within target tissues, supporting continued laboratory investigation of Ovagen in reproductive-biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The development of short peptide bioregulators began in the 1970s at the Military Medical Academy in Saint Petersburg, where Professor Vladimir Khavinson and colleagues isolated peptide fractions from animal tissues that appeared to restore organ-specific function in experimental models. This early work led to the founding of the Saint Petersburg Institute of Bioregulation and Gerontology and the systematic study of tissue-derived peptide complexes such as Epithalamin, Thymalin, and Ovarin.

Ovagen was identified through this research program as a synthetic short peptide bioregulator associated with the ovarian tissue complex. Subsequent biochemical and molecular work explored how such peptides interact with chromatin structure and regulate transcriptional activity, supporting the hypothesis that minimal peptide sequences can act as tissue-specific gene-expression modulators.

Today, Ovagen is positioned within the wider family of Khavinson-school oligopeptides studied for ovarian-tissue gene expression, folliculogenesis research, and peptidergic regulation of female reproductive biology in laboratory research contexts.

1. Chromatin Interaction and Gene Expression

Within the Khavinson framework, Ovagen is proposed to interact with specific regions of double-stranded DNA and associated chromatin proteins, where it may influence the transcriptional activity of genes linked to ovarian-tissue function. This proposed mode of action positions Ovagen as a tool for investigating peptide-mediated gene-expression regulation in reproductive cell models.

2. Ovarian Cell Signaling Modulation

Research observations suggest that Ovagen engages with intracellular signaling pathways relevant to ovarian cell function, including pathways associated with follicular cell communication, steroidogenic enzyme expression, and granulosa cell research models. These observations make Ovagen a useful compound for exploring tissue-specific peptide signaling in vitro.

3. Proliferation and Differentiation Pathways

Comparative work on short peptide bioregulators indicates effects on cellular proliferation, differentiation, and apoptosis within target tissues. In ovarian-tissue research models, Ovagen is investigated for its role in regulating follicular cell turnover, atretic body formation studies, and reproductive-cell renewal pathways.

4. Adaptive and Homeostatic Signaling

Khavinson-school bioregulators are described as adaptive peptide regulators that operate under physiological stress conditions. Ovagen is studied for its proposed contribution to ovarian-tissue homeostasis research, including models of age-related decline in reproductive cell signaling and oxidative stress adaptation.

Research Applications

Conclusion

Ovagen is a Khavinson-school short peptide bioregulator studied for its proposed role in ovarian-tissue gene expression and reproductive cell signaling research. Its compact structure and tissue-targeted positioning make Ovagen a valuable laboratory compound for exploring peptidergic regulation of female reproductive biology in research models.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.